Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Библиографические подробности
Главный автор: Md.Minhaj-Ul-Alam
Другие авторы: Uddin, Md. Jasim
Формат: Диссертация
Язык:English
Опубликовано: Brac University 2021
Предметы:
Online-ссылка:http://hdl.handle.net/10361/15509
id 10361-15509
record_format dspace
spelling 10361-155092021-10-21T21:01:23Z Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession Md.Minhaj-Ul-Alam Uddin, Md. Jasim Department of Pharmacy, Brac University Formulation Transdermal microneedle Covid-19 vaccine COVID-19 (Disease) Vaccines Transdermal medication This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021. Cataloged from PDF version of thesis report. Includes bibliographical references (pages 24-49). Covid-19, a worldwide disease, affects millions of people. As of now, there is no effective technique to avoid infection. This outbreak emphasizes pandemic preparedness. Contrary to popular belief, the Covid-19 vaccination is delivered via transdermal microneedling rather than parenteral administration. Dissolving microneedles are best suited to eliciting the necessary immunity and antibody against Covid-19. It also allows for delayed and sustained antigen delivery, making it an effective pharmacological approach for immunizing. Why Transdermal microneedle vaccine administration allows for individualized distribution and reduced vaccine waste, while parenteral vaccine delivery is intrusive, requires cold chain storage, and does not allow for customized delivery. The challenges of clinical translation and sterilization are simply overcome by greater research. Vaccines are also avoided due to needle phobia, which is eliminated with painless transdermal microneedle delivery. Transdermal microneedle delivery may help us reach our aim of vaccinating as many individuals as possible. Md.Minhaj-Ul-Alam B. Pharmacy 2021-10-21T05:51:31Z 2021-10-21T05:51:31Z 2021 2021-06 Thesis ID 17346058 http://hdl.handle.net/10361/15509 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 49 pages application/pdf Brac University
institution Brac University
collection Institutional Repository
language English
topic Formulation
Transdermal microneedle
Covid-19 vaccine
COVID-19 (Disease)
Vaccines
Transdermal medication
spellingShingle Formulation
Transdermal microneedle
Covid-19 vaccine
COVID-19 (Disease)
Vaccines
Transdermal medication
Md.Minhaj-Ul-Alam
Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
description This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.
author2 Uddin, Md. Jasim
author_facet Uddin, Md. Jasim
Md.Minhaj-Ul-Alam
format Thesis
author Md.Minhaj-Ul-Alam
author_sort Md.Minhaj-Ul-Alam
title Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
title_short Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
title_full Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
title_fullStr Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
title_full_unstemmed Covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
title_sort covid-19 vaccine for transdermal delivery: formulation consideration and microneedle accession
publisher Brac University
publishDate 2021
url http://hdl.handle.net/10361/15509
work_keys_str_mv AT mdminhajulalam covid19vaccinefortransdermaldeliveryformulationconsiderationandmicroneedleaccession
_version_ 1814308817354096640